Session Information
2013 Midyear Clinical Meeting
Click here to go to the previous page
Can't We All Just Get Along? Debates in Chronic Non-Cancer Pain Management (CNCP)
Track: Education Sessions (CE)
Program Code: 213-L01
Date: Tuesday, December 10, 2013
Time: 9:00 AM to 11:00 AM EST
Location: Valencia W415 A, Level 4
PRESENTER(S):
Dr. Ernest Dole, PharmD, BCPS, Pharmaceutical Care Coordinator, Lovelace Medical Group; Internal Medicine
Jeffrey Fudin
Lee Kral
 Mary Lynn McPherson, PharmD, BCPS, Professor and Vice Chair, University of Maryland School of Pharmacy
 Jennifer Strickland, PharmD, BCPS, Co-Director of Center for Advancing QOL (LRMC), Lakeland Regional Medical Center
PROGRAM CHAIR:
Dr. Ernest Dole, PharmD, BCPS, Pharmaceutical Care Coordinator, Lovelace Medical Group; Internal Medicine

  • Apply best evidence for the use of low-dose ketamine for the therapy of Complex Regional Pain Syndrome (CRPS).
  • Assess new information illustrating the point that chronic opioid therapy may cause glial cell inflammation and subsequently cause chronic pain.
  • Discuss the controversies surrounding the change of Drug Enforcement Administration (DEA) classification of hydrocodone from CIII to CII.
  • Evaluate the pros and cons of low-dose naltrexone therapy for Chronic Non-Cancer Pain (CNCP).


Audio Synchronized to PowerPoint
(Code: 213-L01)
Attendee:Free
  
This session is a part of: